CSWM
SNDX icon

Cassady Schiller Wealth Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Cassady Schiller Wealth Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.28K Buy
+97
New +$1.66K ﹤0.01% 715

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Cassady Schiller Wealth Management's SNDX Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Syndax Pharmaceuticals (SNDX) in Q4 2024: 97 shares worth $1.28K. The stake represents ﹤0.01% of the portfolio and ranks #715 among its holdings.

215 funds tracked by Wall St. Rank hold SNDX as of Q4 2024.

  • Cassady Schiller Wealth Management held 97 shares of Syndax Pharmaceuticals worth $1.28K as of Q4 2024.
  • Syndax Pharmaceuticals was a new Cassady Schiller Wealth Management position in Q4 2024.
  • Syndax Pharmaceuticals made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #715 holding.
  • 215 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.